Disc Medicine, Inc. (IRON)

Disc Medicine Statistics

Total Valuation

Disc Medicine has a market cap or net worth of $3.52 billion. The enterprise value is $2.94 billion.

Market Cap	3.52B
Enterprise Value	2.94B

Important Dates

The last earnings date was Thursday, November 6, 2025, before market open.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Disc Medicine has 37.75 million shares outstanding. The number of shares has increased by 27.33% in one year.

Current Share Class	37.75M
Shares Outstanding	37.75M
Shares Change (YoY)	+27.33%
Shares Change (QoQ)	+0.44%
Owned by Insiders (%)	1.07%
Owned by Institutions (%)	87.70%
Float	32.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	5.70
P/TBV Ratio	6.15
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 23.45, with a Debt / Equity ratio of 0.05.

Current Ratio	23.45
Quick Ratio	23.03
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-61.77

Financial Efficiency

Return on equity (ROE) is -34.78% and return on invested capital (ROIC) is -23.69%.

Return on Equity (ROE)	-34.78%
Return on Assets (ROA)	-22.61%
Return on Invested Capital (ROIC)	-23.69%
Return on Capital Employed (ROCE)	-33.73%
Revenue Per Employee	n/a
Profits Per Employee	-$2.16M
Employee Count	84
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Disc Medicine has paid $449,000 in taxes.

Income Tax	449,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +44.46% in the last 52 weeks. The beta is 2.53, so Disc Medicine's price volatility has been higher than the market average.

Beta (5Y)	2.53
52-Week Price Change	+44.46%
50-Day Moving Average	79.89
200-Day Moving Average	59.63
Relative Strength Index (RSI)	66.28
Average Volume (20 Days)	538,376

Short Selling Information

The latest short interest is 3.02 million, so 7.99% of the outstanding shares have been sold short.

Short Interest	3.02M
Short Previous Month	2.87M
Short % of Shares Out	7.99%
Short % of Float	9.26%
Short Ratio (days to cover)	5.20

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-203.60M
Pretax Income	-180.66M
Net Income	-181.11M
EBITDA	-203.40M
EBIT	-203.60M
Earnings Per Share (EPS)	-$5.42

Balance Sheet

The company has $615.92 million in cash and $30.98 million in debt, giving a net cash position of $584.94 million or $15.50 per share.

Cash & Cash Equivalents	615.92M
Total Debt	30.98M
Net Cash	584.94M
Net Cash Per Share	$15.50
Equity (Book Value)	573.39M
Book Value Per Share	16.38
Working Capital	600.42M

Cash Flow

In the last 12 months, operating cash flow was -$164.67 million and capital expenditures -$1.36 million, giving a free cash flow of -$166.03 million.

Operating Cash Flow	-164.67M
Capital Expenditures	-1.36M
Free Cash Flow	-166.03M
FCF Per Share	-$4.40

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Disc Medicine does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-27.33%
Shareholder Yield	-27.33%
Earnings Yield	-5.14%
FCF Yield	-4.71%

Analyst Forecast

The average price target for Disc Medicine is $108.83, which is 16.71% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$108.83
Price Target Difference	16.71%
Analyst Consensus	Strong Buy
Analyst Count	12
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2